Recent news reveal a significant level of activity surrounding
Bio-Techne Corp TECH. The company's shares were acquired by prominent asset managing firms such as
Cwm LLC and
PNC Financial Services Group. However,
Vanguard Group notably sold a substantial portion of their shares. Financial performance has seen highs and lows, with recent Q4 results causing a decline in
TECH stock. However, the company's shares are still considered to be potentially well above their intrinsic value. Bio-Techne has announced numerous presentations at upcoming investor conferences, highlighting their
RNAscope technology, alongside their
MauriceFlex™ System. Important legal activities include a patent infringement lawsuit against
Molecular Instruments. The corporation continues to make strategic moves, announcing a new distribution agreement with
Thermo Fisher Scientific and a partnership with
Nikon Instruments. In terms of leadership,
Dr. Judith Klimovsky has been appointed to the board of directors, and
Kim Kelderman has been named as the new CEO.
Bio-Techne Corp TECH News Analytics from Wed, 03 Mar 2021 08:00:00 GMT to Sun, 23 Jun 2024 09:49:11 GMT -
Rating 7
- Innovation 5
- Information 8
- Rumor -3
